Skip to main content

Overview

Event Details

Travere Therapeutics Fourth Quarter and Full Year 2023 Earnings Results

February 15, 2024 4:30 PM ET

Quick Links

SEC Filings opens in new window
Investor Q&A opens in new window
Contact Us opens in new window

Investor Email Alerts

Personal Information.

Email Address *Required Email Address is required. Email Address is invalid.

Investor Alert Options *

News
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote
Events & Presentations

Investor Alert Options is required.

The captcha test has failed. Please try again.

By clicking "Submit," I am submitting my contact information and may receive company communications from Travere. All personal data will be processed by or on behalf of Travere to provide access to company information and to respond to requests. Travere will retain personal data only for as long as is required to complete the purposes for which it was collected and to fulfill its legal, regulatory, or reporting obligations. Travere understands personal data is private and will not disseminate it to third parties who are not providing services to Travere. You may unsubscribe at any time. For more information, review the Travere privacy policies.

Terms of Use
Privacy Policy
Do Not Sell or Share My Personal Information

©2026 Travere Therapeutics, Inc. All rights reserved. For U.S. audiences.
Total Care Hub®, Travere TotalCare®, and Filspari® are registered
trademarks of Travere Therapeutics. Thiola® and Thiola EC® are
registered trademarks of Mission Pharmacal Company.